Wed. 24 Apr 2024, 3:58pm ET
Benzinga
Biotech, News, General
InMed Pharmaceuticals Has Received A Notice Of Allowance For Its U.S. Patent Application 16/644,484 Titled "Metabolic Engineering Of E. Coli For The Biosynthesis Of Cannabinoid Products"
Company Profile